# Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

> **NCT00001752** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 30 (—)

## Conditions studied

- Hypercholesterolemia
- Postmenopause

## Interventions

- **DRUG:** L-arginine
- **DRUG:** Estrogen

## Key facts

- **NCT ID:** NCT00001752
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** 2000-07
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001752, "Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00001752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*